View in EDS

An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy.

Saved in:
Bibliographic Details
Title: An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy.
Authors: Blaye C; Department of Medical Oncology, Institut Bergonié, Bordeaux, France; Univ. Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France., Darbo É; Univ. Bordeaux, INSERM U1218, ACTION Laboratory, Bordeaux, France., Debled M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Brouste V; Departments of Clinical Research and Medical Information, Bordeaux, France., Vélasco V; Biopathology, Institut Bergonié, Bordeaux, France., Pinard C; Pathology Laboratory, University Hospital of Martinique, Fort de France., Larmonier N; Univ. Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France; Univ. Bordeaux, Bordeaux, France., Pellegrin I; Service d'Immunologie et Immunogénétique, University Hospital of Bordeaux, Bordeaux, France; Centre de Ressources Biologiques Plurithématique, University Hospital of Bordeaux, Bordeaux, France., Tarricone A; Service d'Immunologie et Immunogénétique, University Hospital of Bordeaux, Bordeaux, France., Arnedos M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Commeny J; Department of Surgery, Institut Bergonié, Bordeaux, France., Bonnefoi H; Department of Medical Oncology, Institut Bergonié, Bordeaux, France; Univ. Bordeaux, INSERM U1218, ACTION Laboratory, Bordeaux, France; Univ. Bordeaux, Bordeaux, France., Larmonier C; Biopathology, Institut Bergonié, Bordeaux, France., MacGrogan G; Univ. Bordeaux, INSERM U1218, ACTION Laboratory, Bordeaux, France; Biopathology, Institut Bergonié, Bordeaux, France. Electronic address: g.macgrogan@bordeaux.unicancer.fr.
Source: ESMO open [ESMO Open] 2022 Aug; Vol. 7 (4), pp. 100502. Date of Electronic Publication: 2022 Jun 24.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35759853
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Blaye+C%22">Blaye C</searchLink>; Department of Medical Oncology, Institut Bergonié, Bordeaux, France; Univ. Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Darbo+É%22">Darbo É</searchLink>; Univ. Bordeaux, INSERM U1218, ACTION Laboratory, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Debled+M%22">Debled M</searchLink>; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Brouste+V%22">Brouste V</searchLink>; Departments of Clinical Research and Medical Information, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Vélasco+V%22">Vélasco V</searchLink>; Biopathology, Institut Bergonié, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Pinard+C%22">Pinard C</searchLink>; Pathology Laboratory, University Hospital of Martinique, Fort de France.<br /><searchLink fieldCode="AU" term="%22Larmonier+N%22">Larmonier N</searchLink>; Univ. Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France; Univ. Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Pellegrin+I%22">Pellegrin I</searchLink>; Service d'Immunologie et Immunogénétique, University Hospital of Bordeaux, Bordeaux, France; Centre de Ressources Biologiques Plurithématique, University Hospital of Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Tarricone+A%22">Tarricone A</searchLink>; Service d'Immunologie et Immunogénétique, University Hospital of Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Arnedos+M%22">Arnedos M</searchLink>; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Commeny+J%22">Commeny J</searchLink>; Department of Surgery, Institut Bergonié, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Bonnefoi+H%22">Bonnefoi H</searchLink>; Department of Medical Oncology, Institut Bergonié, Bordeaux, France; Univ. Bordeaux, INSERM U1218, ACTION Laboratory, Bordeaux, France; Univ. Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Larmonier+C%22">Larmonier C</searchLink>; Biopathology, Institut Bergonié, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22MacGrogan+G%22">MacGrogan G</searchLink>; Univ. Bordeaux, INSERM U1218, ACTION Laboratory, Bordeaux, France; Biopathology, Institut Bergonié, Bordeaux, France. Electronic address: g.macgrogan@bordeaux.unicancer.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2022 Aug; Vol. 7 (4), pp. 100502. <i>Date of Electronic Publication: </i>2022 Jun 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35759853
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.esmoop.2022.100502
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100502
    Titles:
      – TitleFull: An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Blaye C
      – PersonEntity:
          Name:
            NameFull: Darbo É
      – PersonEntity:
          Name:
            NameFull: Debled M
      – PersonEntity:
          Name:
            NameFull: Brouste V
      – PersonEntity:
          Name:
            NameFull: Vélasco V
      – PersonEntity:
          Name:
            NameFull: Pinard C
      – PersonEntity:
          Name:
            NameFull: Larmonier N
      – PersonEntity:
          Name:
            NameFull: Pellegrin I
      – PersonEntity:
          Name:
            NameFull: Tarricone A
      – PersonEntity:
          Name:
            NameFull: Arnedos M
      – PersonEntity:
          Name:
            NameFull: Commeny J
      – PersonEntity:
          Name:
            NameFull: Bonnefoi H
      – PersonEntity:
          Name:
            NameFull: Larmonier C
      – PersonEntity:
          Name:
            NameFull: MacGrogan G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2059-7029
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: ESMO open
              Type: main
ResultId 1